MASLD

Integrated Ultrasound-Derived Fat Fraction and 2D/4D HeartAI for Cardiovascular Risk Management in Patients With MASLD

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

Structured Physical Activity Intervention in Patients With MASLD Receiving a Mediterranean Diet

Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve Long-term Clinical Outcomes in MASLD

A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Quantitative Ultrasound to Assess Steatotic Liver Disease in Children

Dietary Strategies for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)

Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery

Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI

Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis

High Fructose Diet, the Gut Microbiome, and Metabolic Health

Ultrasound-Based Estimation of Hepatic Steatosis in Pediatric MASLD

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

DEFINITION OF THE GENOMIC LANDSCAPE OF MASLD

Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease.

NAFLD Clinical Care Pathway

Digoxin In NASH (CODIN)